ResMed Market Cap

ResMed has a market cap or net worth of $37.39 billion as of December 5, 2025. Its market cap has increased by 7.01% in one year.

Market Cap

37.39B

Enterprise Value

36.86B

Revenue

5.26B

Ranking

n/a

PE Ratio

26.01

Stock Price

$27.25

Market Cap Chart

Since June 2, 1995, ResMed's market cap has increased from 38.59M to 37.39B, an increase of 96,791.69%. That is a compound annual growth rate of 25.26%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	37.39B	11.35%
Dec 31, 2024	33.58B	32.73%
Dec 29, 2023	25.30B	-17.24%
Dec 30, 2022	30.57B	-19.72%
Dec 31, 2021	38.08B	23.63%
Dec 31, 2020	30.80B	38.24%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Veradigm	815.80M
Elite Pharmaceuticals	569.32M
Glass House Brands	503.27M
CytoDyn	416.55M
American Oncology Network	367.13M
Northwest Biotherapeutics	359.36M
Silence Therapeutics	295.21M
Nika Pharmaceuticals	259.91M

Market Cap Rankings